Gel-Based ABO Antibody Titration Is Unreliable in Organ Transplantation

Myth: Gel-Based ABO Antibody Titration Is Unreliable in Organ Transplantation

ABO-Incompatible Solid Organ Transplantation

In ABO-incompatible solid organ transplantation – particularly kidney and liver transplants – monitoring IgG anti-A or anti-B titers is central to assessing patient eligibility, guiding desensitization, and detecting post-transplant antibody rebound. Some clinicians and labs, however, have been wary of using gel-based titration methods, citing concerns about higher titer values or poor comparability to traditional tube titers.

Consistency Over Time

This view is outdated. Gel titration methods actually offer superior[1] reproducibility and objectivity. Unlike manual tube techniques, which are time consuming and suffer from operator-dependent variability in dilution preparation, incubation times, and subjective endpoint reading. Gel systems produce cleaner endpoints with less inter-observer discrepancy.[2,3] It’s true that gel methods may yield higher absolute titer values than tube methods, but what matters most is consistency over time, not the absolute number. If you stick with one method per patient (which is key), a gel titration is an ideal tool for tracking trends by the instrument software.[4]

Gel Titers Help Gauge Treatment Response

For example, in ABO-incompatible kidney transplantation, many centers aim for pre-transplant IgG titers of <16 ≤1:16 before proceeding with the transplant. During desensitization (plasmapheresis, immunosuppression, etc.), gel titers help gauge treatment response. Post-operatively, a rising titer in gel can signal antibody-mediated rejection brewing – prompting early intervention. In all these scenarios, the trend and change in titer is what guides management, and gel’s precision excels at showing true changes rather than variability introduced by manual testing.[1]

Clarity and Standardization

Multiple studies and transplant programs have validated gel titration demonstrating that IgG gel methods yield median titers that differ by only one doubling dilution,[5] which is within the limits of reproducibility set out in the AABB Technical Manual. Moreover, gel card methods demonstrate better clinical correlation than tube titers.[1,3]  The clarity and standardization of gel testing often lead to improved confidence among clinicians interpreting the results.

The Importance of Correct Interpretation

So no – gel-based titration isn’t unreliable. Misusing it (for example, by switching back and forth between methods or fixating on absolute numbers instead of trends) is what can be unreliable. When used consistently, gel titers are a robust tool in the ABO-incompatible transplant setting.[5] The method itself is sound; it’s the interpretation that needs to be done correctly.